BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16479254)

  • 1. Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours.
    Wang Y; Hewitt SM; Liu S; Zhou X; Zhu H; Zhou C; Zhang G; Quan L; Bai J; Xu N
    Br J Cancer; 2006 Mar; 94(5):686-91. PubMed ID: 16479254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FRAT1 overexpression leads to aberrant activation of beta-catenin/TCF pathway in esophageal squamous cell carcinoma.
    Wang Y; Liu S; Zhu H; Zhang W; Zhang G; Zhou X; Zhou C; Quan L; Bai J; Xue L; Lu N; Xu N
    Int J Cancer; 2008 Aug; 123(3):561-8. PubMed ID: 18498136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Frat1 correlates with expression of β-catenin and is associated with a poor clinical outcome in human SCC and AC.
    Zhang Y; Han Y; Zheng R; Yu JH; Miao Y; Wang L; Wang EH
    Tumour Biol; 2012 Oct; 33(5):1437-44. PubMed ID: 22528942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
    Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
    Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of FRAT1 inhibits hypoxia-induced epithelial-to-mesenchymal transition via suppression of the Wnt/β-catenin pathway in hepatocellular carcinoma cells.
    Fan WH; Du FJ; Liu XJ; Chen N
    Oncol Rep; 2016 Nov; 36(5):2999-3004. PubMed ID: 27666874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas.
    Shedden KA; Kshirsagar MP; Schwartz DR; Wu R; Yu H; Misek DE; Hanash S; Katabuchi H; Ellenson LH; Fearon ER; Cho KR
    Clin Cancer Res; 2005 Mar; 11(6):2123-31. PubMed ID: 15788657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequently rearranged in advanced T‑cell lymphomas‑1 demonstrates oncogenic properties in prostate cancer.
    Zhang W; Xiong H; Zou Y; Xu S; Quan L; Yuan X; Xu N; Wang Y
    Mol Med Rep; 2016 Oct; 14(4):3551-8. PubMed ID: 27599661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FRAT1 promotes the angiogenic properties of human glioblastoma cells via VEGFA.
    Yang B; Liu D; Ren YQ; Sun YQ; Zhang JP; Wang XG; Wu YQ; Wang SL; Guo SH; Guo G
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35059733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of β-catenin and cyclinD1 predicts a poor prognosis in ovarian serous carcinomas.
    Wang H; Wang H; Makki MS; Wen J; Dai Y; Shi Q; Liu Q; Zhou X; Wang J
    Int J Clin Exp Pathol; 2014; 7(1):264-71. PubMed ID: 24427347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse model of human ovarian endometrioid adenocarcinoma based on somatic defects in the Wnt/beta-catenin and PI3K/Pten signaling pathways.
    Wu R; Hendrix-Lucas N; Kuick R; Zhai Y; Schwartz DR; Akyol A; Hanash S; Misek DE; Katabuchi H; Williams BO; Fearon ER; Cho KR
    Cancer Cell; 2007 Apr; 11(4):321-33. PubMed ID: 17418409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression profile of FRAT1 in human gliomas.
    Guo G; Mao X; Wang P; Liu B; Zhang X; Jiang X; Zhong C; Huo J; Jin J; Zhuo Y
    Brain Res; 2010 Mar; 1320():152-8. PubMed ID: 20096670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between LRP5 and Frat1 mediates the activation of the Wnt canonical pathway.
    Hay E; Faucheu C; Suc-Royer I; Touitou R; Stiot V; Vayssière B; Baron R; Roman-Roman S; Rawadi G
    J Biol Chem; 2005 Apr; 280(14):13616-23. PubMed ID: 15699046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients.
    Kildal W; Risberg B; Abeler VM; Kristensen GB; Sudbø J; Nesland JM; Danielsen HE
    Eur J Cancer; 2005 May; 41(8):1127-34. PubMed ID: 15911235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel candidate targets of beta-catenin/T-cell factor signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas.
    Schwartz DR; Wu R; Kardia SL; Levin AM; Huang CC; Shedden KA; Kuick R; Misek DE; Hanash SM; Taylor JM; Reed H; Hendrix N; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2003 Jun; 63(11):2913-22. PubMed ID: 12782598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
    Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FRAT1 Enhances the Proliferation and Tumorigenesis of CD133
    Guo G; Liu J; Ren Y; Mao X; Hao Y; Zhong C; Chen X; Wang X; Wu Y; Lian S; Mei L; Zhao Y
    J Cancer; 2020; 11(9):2421-2430. PubMed ID: 32201513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The miR-3648/FRAT1-FRAT2/c-Myc negative feedback loop modulates the metastasis and invasion of gastric cancer cells.
    Tang W; Pei M; Li J; Xu N; Xiao W; Yu Z; Zhang J; Hong L; Guo Z; Lin J; Dai W; Xiao Y; Wu X; Liu G; Zhi F; Li G; Xiong J; Chen Y; Zhang H; Xiang L; Li A; Liu S; Wang J
    Oncogene; 2022 Oct; 41(43):4823-4838. PubMed ID: 36153370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FRAT1 expression and its correlation with pathologic grade, proliferation, and apoptosis in human astrocytomas.
    Guo G; Liu B; Zhong C; Zhang X; Mao X; Wang P; Jiang X; Huo J; Jin J; Liu X; Chen X
    Med Oncol; 2011 Mar; 28(1):1-6. PubMed ID: 20041315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of secreted frizzled-related protein 4 (SFRP4) in primary serous ovarian tumours.
    Drake J; Shearwood AM; White J; Friis R; Zeps N; Charles A; Dharmarajan A
    Eur J Gynaecol Oncol; 2009; 30(2):133-41. PubMed ID: 19480240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.
    Madore J; Ren F; Filali-Mouhim A; Sanchez L; Köbel M; Tonin PN; Huntsman D; Provencher DM; Mes-Masson AM
    J Pathol; 2010 Feb; 220(3):392-400. PubMed ID: 19967725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.